| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |